1,720,967 research outputs found
Neuropati Perifer pada Penyintas Kanker Ovarium di RSUP Haji Adam Malik
No full textBackground. Cancer is the second leading cause of death in the world and ovarian cancer is one of them. In 2018, ovarian cancer was ranked 8th among other types of cancer that cause death in women. Ovarian cancer management is very much determined by the stage, degree of differentiation, fertility and general condition of the patient. Cytoreduction surgery and chemotherapy are therapeutic options in ovarian cancer. Paclitaxel-Carboplatin is a combination drug used in chemotherapy. This combination of drugs often causes side effects in the form of peripheral neuropathy. Chemotherapy-induced peripheral neraopathy can include sensory neuropathy and motor neuropathy. Assessment of chemotherapy-induced peripheral neuropathy in ovarian cancer survivors can use EORTC QLQ-CIPN20. Purpose. This study aims to determine the most dominant chemotherapy-induced peripheral neuropathy symptoms felt by ovarian cancer survivors. Research methods. This study used a descriptive-analytic research method with a cross sectional model using primary data from telephone interviews using the EORTC QLQ-CIPN20 questionnaire, as well as secondary data from medical records at Haji Adam Malik Medan Hospital. The research sample was selected by total sampling method from all medical records that met the inclusion and exclusion criteria of the study. Result. Of the 35 survivors of ovarian cancer in 2017-2020, it was found that the largest age group was in the 51-60 years age group (34.3%), the type of therapy was surgery + adjuvant chemotherapy (71.4%), the duration of therapy was 4-7 months (65.7%), histopathological form of epithelial (82.9%) and unknown amounted to 5.7%, stage II (37.1%) and unknown amounted to 11.4%. 74.3% of chemotherapy-induced peripheral neuropathy symptoms were mild symptoms and 11.4% were moderate symptoms. The dominant symptoms felt by ovarian cancer survivors were numbness, cramps in both hands and feet (29.52% and 12.38%), and dizziness after changing positions (14.29%). Conclusion. The most dominant chemotherapy-induced peripheral neuropathy symptoms felt by ovarian cancer survivors were numbness and cramps in both hands and feet, and dizziness after changing positions.Latar Belakang. Kanker merupakan penyebab utama kematian kedua di dunia dan kanker ovarium merupakan salah satunya. Pada tahun 2018, tercatat kanker ovarium menempati peringkat ke-8 dari berbagai jenis kanker lainnya yang menyebabkan kematian pada perempuan. Penatalaksanaan kanker ovarium sangat ditentukan oleh stadium, derajat diferensiasi, fertilitas dan keadaan umum penderita. Operasi sitoreduksi dan kemoterapi merupakan pilihan terapi dalam kanker ovarium. Paclitaxel-Carboplatin merupakan salah satu kombinasi obat yang digunakan dalam kemoterapi. Kombinasi obat ini sering kali menimbulkan efek samping berupa neuropati perifer. Nueropati perifer terinduksi kemoterapi dapat berupa neruopati sensorik dan neuropati motorik. Penilaian neuropati perifer terinduksi kemoterapi pada penyintas kanker ovarium dapat menggunakan EORTC QLQ-CIPN20. Tujuan. Penelitian ini bertujuan untuk mengetahui gejala neuropati perifer terinduksi kemoterapi yang paling dominan dirasakan penyintas kanker ovarium. Metode Penelitian. Penelitian ini menggunakan metode penelitian deskriptif-analitik dengan model cross sectional dengan menggunakan data primer dari hasil wawancara melalui telepon menggunakan kuesioner EORTC QLQ-CIPN20, serta data sekunder yang berasal dari rekam medis di RSUP Haji Adam Malik Medan. Sampel penelitian dipilih dengan metode total sampling dari seluruh data rekam medis yang memenuhi kriteria inklusi dan eksklusi penelitian. Hasil. Dari 35 penyintas kanker ovarium tahun 2017-2020 didapatkan bahwa usia terbanyak terdapat pada kelompok usia 51-60 tahun (34.3%), jenis terapi berupa pembedahan + kemoterapi adjuvant (71.4%), lama terapi 4-7 bulan (65.7%), jenis histopatologis berupa epithelial (82.9%) dan tidak diketahui sebesar 5.7%, stadium II (37.1%) dan tidak diketahui sebesar 11.4%. Gejala neuropati perifer terinduksi kemoterapi penyintas kanker ovarium sebesar 74.3% adalah gejala ringan dan 11.4% adalah gejala sedang. Gejala yang dominan dirasakan penyintas kanker ovarium berupa kebas, dan kram baik pada tangan maupun kaki (29.52% dan 12.38%), serta pusing setelah mengubah posisi (14.29%). Kesimpulan. Gejala neuropati perifer terinduksi kemoterapi yang paling dominan dirasakan penyintas kanker ovarium berupa kebas dan kram baik pada tangan maupun kaki, serta pusing setelah mengubah posisi.85 HalamanSkripsi Sarjan
Hubungan antara Nyeri Punggung Bawah (Low Back Pain) dengan Status Fungsional dan Kualitas Hidup pada Ibu Hamil Trimester II dan III di Puskesmas Padang Bulan Tahun 2023
Get PDFBackground
. Pregnancy can cause physiological changes on a woman's body.
The most common changes during pregnancy are changes in the musculoskeletal
system. In pregnancy, there is a change in posture due to a shift in the center of
gravity due to the growth of the fetus, this change in the posture can cause tension
in the lower back causing discomfort in the form of low back pain or LBP on
pregnancy and will worsen with the development of pregnancies especially in the
second and third trimesters. Objective. The purpose of this study to k now the
corrrelation between low back pain and functional status and quality of life in
pregnant women in trimester II and III at the Puskesmas Padang Bulan. Methods.
The research was done using a decriptive method with a cross sectional design.
The data was obtained using VAS, ODI, and SF 36 questionnaires given to
pregnant women of trimester II and III in the Puskesmas Padang Bulan The
analysis used was univariate an d bivariate analysis with chi square. Results. Out
of 83 respondents, 77 respondents met the inclusion criteria s . The results of
statistical analysis indicate that there is a relationship between LBP and
functional status (p=0.004) as well as quality of li fe in the body pain domain (p
=0.001) and emotional limitation (P=0.001). Conclusion. There is a correlation
between LBP with functional status and quality of life of the body pain domain
and the emotional limitation of pregnant wome n in the second and th ird
trimesters.93 PagesSkripsi Sarjan
Kualitas Hidup Penyintas Kanker Ovarium di Rsup Haji Adam Malik Medan
No full textIntoduction. Ovarian cancer has a high mortality rate due to nonspecific symptoms, often found at
an advanced stage, and also the absence of proven early detection methods. To assess the success
of ovarian cancer survivors therapy, it is not only assessed from the clinical aspect but also from
the quality of life of ovarian cancer survivors whose assessment is based on the functional scale
and symptom scale in the EORTC QLQ C30 and EORTC QLQ OV28 questionnaires. Objective.
This study aims to determine how the quality of life of ovarian cancer survivors. Method. This
study uses a cross sectional study design, using primary data from interviews with the
questionnaire EORTC QLQ C30 and EORTC QLQ OV28 as well as secondary data obtained from
medical records at RSUP Haji Adam Malik Medan in 2017 - 2018. The research sample was used
with a total sampling method from all medical record data that include the research criteria.
Result. From 47 ovarian cancer survivors in 2017-2018, it was found that the most age in the age
group 50-59 years (40.4%), histopathological type in the form of epithelial tumors (87.2%), stage
III (42.6%), type of therapy in the form of surgery + adjuvant chemotherapy ( 80.9%), duration of
therapy 4-7 months (87.2%). The global quality of life of ovarian cancer survivors 89.36% is
good, and 10.64% is moderate and no one has a poor quality of life. However, there are disorders
on the functional scale in the form of: emotional function, cognitive function, sexual function, and
attitude toward disease, likewise on the scale of symptoms there are problems such as: fatigue,
pain, peripheral neuropathy, and menopausal symptoms. These results indicate no relationship
between the characteristics of age, histopathological type, stage, and duration of therapy, but
there is a relationship between the type of therapy with the quality of life of ovarian cancer
survivors. Conclusion. The quality of life of ovarian cancer survivors globally is fair.Latar Belakang. Kanker ovarium memiliki angka mortalitas yang tinggi karena gejalanya yang
tidak spesifik, sering ditemukan pada stadium lanjut, dan juga belum adanya metode deteksi dini
yang sudah terbukti. Untuk menilai keberhasilan terapi penyintas kanker ovarium, tidak hanya
dinilai dari aspek klinis tetapi juga dinilai dari kualitas hidup penyintas kanker ovarium yang
penilaiannya berdasarkan skala fungsional dan skala gejala dalam kuesioner EORTC QLQ C30
dan EORTC QLQ OV28. Tujuan. Penelitian ini bertujuan untuk mengetahui kualitas hidup
penyintas kanker ovarium. Metode. Penelitian ini menggunakan desain penelitian cross sectional,
menggunakan data primer dari hasil wawancara dengan kuesioner EORTC QLQ C30 dan
EORTC QLQ OV28 serta data sekunder yang berasal dari rekam medik di RSUP Haji Adam
Malik Medan tahun 2017 - 2018. Sampel penelitian dipilih dengan metode total sampling dari
seluruh data rekam medik yang memenuhi kriteria penelitian. Hasil. Dari 47 penyintas kanker
ovarium tahun 2017-2018 didapatkan bahwa usia terbanyak pada kelompok usia 50-59 tahun
(40.4%), jenis histopatologis berupa epithelial tumors (87.2%), stadium III (42.6%), Jenis terapi
berupa pembedahan + kemoterapi adjuvant (80.9%), lama terapi 4-7 bulan (87.2%). Kualitas
hidup global penyintas kanker ovarium 89.36% adalah baik, dan 10.64% adalah sedang serta
tidak ada yang memiliki kualitas hidup buruk. Namun, didapatkan adanya gangguan pada skala
fungsional berupa: fungsi emosional, fungsi kognitif, fungsi seksual, dan sikap terhadap penyakit,
serta adanya permasalahan pada skala gejala berupa: kelelahan, nyeri, neuropati perifer, dan
gejala menopause. Hasil ini menunjukkan tidak ada hubungan karakteristik usia, jenis
histopatologis, stadium, dan lama terapi, namun terdapat hubungan antara jenis terapi dengan
kualitas hidup penyintas kanker ovarium.. Kesimpulan. Kualitas hidup penyintas kanker ovarium
secara global adalah baik.85 HalamanSkripsi Sarjan
Neuropati Perifer pada Penyintas Kanker Ovarium di RSUP Haji Adam Malik
No full textBackground. Cancer is the second leading cause of death in the world and ovarian cancer is one of them. In 2018, ovarian cancer was ranked 8th among other types of cancer that cause death in women. Ovarian cancer management is very much determined by the stage, degree of differentiation, fertility and general condition of the patient. Cytoreduction surgery and chemotherapy are therapeutic options in ovarian cancer. Paclitaxel-Carboplatin is a combination drug used in chemotherapy. This combination of drugs often causes side effects in the form of peripheral neuropathy. Chemotherapy-induced peripheral neraopathy can include sensory neuropathy and motor neuropathy. Assessment of chemotherapy-induced peripheral neuropathy in ovarian cancer survivors can use EORTC QLQ-CIPN20. Purpose. This study aims to determine the most dominant chemotherapy-induced peripheral neuropathy symptoms felt by ovarian cancer survivors. Research methods. This study used a descriptive-analytic research method with a cross sectional model using primary data from telephone interviews using the EORTC QLQ-CIPN20 questionnaire, as well as secondary data from medical records at Haji Adam Malik Medan Hospital. The research sample was selected by total sampling method from all medical records that met the inclusion and exclusion criteria of the study. Result. Of the 35 survivors of ovarian cancer in 2017-2020, it was found that the largest age group was in the 51-60 years age group (34.3%), the type of therapy was surgery + adjuvant chemotherapy (71.4%), the duration of therapy was 4-7 months (65.7%), histopathological form of epithelial (82.9%) and unknown amounted to 5.7%, stage II (37.1%) and unknown amounted to 11.4%. 74.3% of chemotherapy-induced peripheral neuropathy symptoms were mild symptoms and 11.4% were moderate symptoms. The dominant symptoms felt by ovarian cancer survivors were numbness, cramps in both hands and feet (29.52% and 12.38%), and dizziness after changing positions (14.29%). Conclusion. The most dominant chemotherapy-induced peripheral neuropathy symptoms felt by ovarian cancer survivors were numbness and cramps in both hands and feet, and dizziness after changing positions.Latar Belakang. Kanker merupakan penyebab utama kematian kedua di dunia dan kanker ovarium merupakan salah satunya. Pada tahun 2018, tercatat kanker ovarium menempati peringkat ke-8 dari berbagai jenis kanker lainnya yang menyebabkan kematian pada perempuan. Penatalaksanaan kanker ovarium sangat ditentukan oleh stadium, derajat diferensiasi, fertilitas dan keadaan umum penderita. Operasi sitoreduksi dan kemoterapi merupakan pilihan terapi dalam kanker ovarium. Paclitaxel-Carboplatin merupakan salah satu kombinasi obat yang digunakan dalam kemoterapi. Kombinasi obat ini sering kali menimbulkan efek samping berupa neuropati perifer. Nueropati perifer terinduksi kemoterapi dapat berupa neruopati sensorik dan neuropati motorik. Penilaian neuropati perifer terinduksi kemoterapi pada penyintas kanker ovarium dapat menggunakan EORTC QLQ-CIPN20. Tujuan. Penelitian ini bertujuan untuk mengetahui gejala neuropati perifer terinduksi kemoterapi yang paling dominan dirasakan penyintas kanker ovarium. Metode Penelitian. Penelitian ini menggunakan metode penelitian deskriptif-analitik dengan model cross sectional dengan menggunakan data primer dari hasil wawancara melalui telepon menggunakan kuesioner EORTC QLQ-CIPN20, serta data sekunder yang berasal dari rekam medis di RSUP Haji Adam Malik Medan. Sampel penelitian dipilih dengan metode total sampling dari seluruh data rekam medis yang memenuhi kriteria inklusi dan eksklusi penelitian. Hasil. Dari 35 penyintas kanker ovarium tahun 2017-2020 didapatkan bahwa usia terbanyak terdapat pada kelompok usia 51-60 tahun (34.3%), jenis terapi berupa pembedahan + kemoterapi adjuvant (71.4%), lama terapi 4-7 bulan (65.7%), jenis histopatologis berupa epithelial (82.9%) dan tidak diketahui sebesar 5.7%, stadium II (37.1%) dan tidak diketahui sebesar 11.4%. Gejala neuropati perifer terinduksi kemoterapi penyintas kanker ovarium sebesar 74.3% adalah gejala ringan dan 11.4% adalah gejala sedang. Gejala yang dominan dirasakan penyintas kanker ovarium berupa kebas, dan kram baik pada tangan maupun kaki (29.52% dan 12.38%), serta pusing setelah mengubah posisi (14.29%). Kesimpulan. Gejala neuropati perifer terinduksi kemoterapi yang paling dominan dirasakan penyintas kanker ovarium berupa kebas dan kram baik pada tangan maupun kaki, serta pusing setelah mengubah posisi.85 HalamanSkripsi Sarjan
Profile Of Dietary Inflammatory Index (DII) Scores among Ovarian Cancer Patients: A Case Series Study
No full textBackground: Ovarian cancer remains one of the gynecological malignancies with
the highest mortality rates in both Indonesia and globally. Dietary patterns play a
crucial role in modulating chronic inflammation, which may contribute to the
development and progression of ovarian cancer. The Dietary Inflammatory Index
(DII) is a validated tool used to evaluate the overall inflammatory potential of an
individual’s diet. Objective: To describe the DII scores among ovarian cancer
patients at Prof. dr. Chairuddin P. Lubis Universitas Sumatera Utara Hospital,
Universitas Sumatera Utara, Medan, 20155, Indonesia and Grandmed Hospital,
Lubuk Pakam. Methods: This study employed a descriptive design with a case
series approach. Samples were obtained using a total sampling technique,
including all ovarian cancer patients who met the inclusion criteria during the
period of July to September 2025. Dietary intake was assesed using a Semi-
Quantitative Food Frequency Questionnaire (SQ-FFQ), converted into nutrient
daily intake using Nutrisurvey software, and aggregated to calculate the DII score
based on global reference values. Results: A total of 53 respondents participated in
the study. Most patients were adult women aged 40 – 60 years (54,7%),
predominantly housewives (83%) with the majority of the histopathological types
are high grade serous carcinomas (30,2%). The mean DII score was +3,06 ± 0,69,
indicating a generally proinflammatory dietary pattern. The mean daily intake of
energy (2.137,54 ± 270,17) and fat (109,12 ± 22,59) exceeded the global daily mean
intake for these nutrient parameters. Conclusion: The majority of ovarian cancer
patients exhibited positive DII scores, reflecting a proinflammatory dietary pattern.92 PagesSkripsi Sarjan
Effectiveness of Simvastatin 20 Mg on Uterine Fibroid Size Reduction
No full textBackground. Uterine fibroids are benign growths in the uterus made of smooth muscle cells, fibroblasts, and Extracellular Matrix (ECM). They develop and respond to hormonal changes in women between puberty and menopause, causing symptoms like heavy menstrual bleeding, anemia, enlarged uterus, urinary or gastrointestinal issues, bloating, and pain. Simvastatin is a drug that inhibits the enzyme HMG-CoA reductase, which is involved in cholesterol synthesis. Simvastatin has been found to inhibit cell growth and induce apoptosis in uterine fibroid cells by affecting ERK and AKT activation. In xenograft mouse models, simvastatin decreased tumor volume in fibroid tissues, suggesting it as a potential treatment for uterine fibroids.
Method. This is a quasi-experimental study with pre and post study approach to evaluate the effect on uterine fibroid size reduction after administering Simvastatin 20 mg for 12 weeks in Prof. dr. CPL USU Hospital and Stella Maris Maternal and Children Hospital. Consecutive sampling was used as the sampling technique in this study.
Results. From 35 sample, based on age, majority of subjects were on group age 41-50 years, totaling 19 samples (54.3%), based on BMI, majority of subjects had obesity, accounting for 25 samples (71.4%), and based on parity status, majority of subjects were nulliparous, accounting for 14 samples (40%). Majority of samples had one uterine fibroid lesion, 23 patients (65.7%), while the most frequent location of uterine fibroid was the corpus, 23 patients (65.7%) with the type of uterine fibroid that is most often found being submucosa, 14 patients (40%). Before simvastatin 20mg administration, median size of uterine fibroid was 69.92 cm while after administration of simvastatin 20 mg it was 25.34 cm3 (p<0.001). The median decrease in uterine fibroid volume was 0.5 cm3. In this study, 11 patients (31.4%) experienced side effects such as myalgia and no other side effects were found.
Conclusion. Majority of the samples were on group age of 41-50 years, had obesity, and nulliparous. We found a size reduction of uterine fibroids after administering simvastatin 20mg for 12 weeks were 2.43 cm3 (p < 0.001), Myalgia was the only side effect after simvastatin 20 mg administration reported in this study.94 PagesTesis Magiste
Perbedaan Hasil Pemeriksaan Doppler Umbilikal Arteri, Gambaran Kardiotokografi, Kadar Asam Laktat Tali Pusat Janin Baru Lahir dan Skor APGAR pada Ibu Hamil Normal dan Hamil Risiko Tinggi Trimester III
No full textLatar Belakang : Tingginya angka kematian bayi baru lahir akibat asfiksia menunjukkan masih tingginya kegagalan penanganan dan pencegahan yang komprehensif terhadap bayi baru lahir. Oleh karena itu, diperlukan pemeriksaan yang efektif dan efisien dalam memprediksi terjadinya risiko gawat janin.
Tujuan: Mengetahui perbedaan doppler umbilikal arteri janin, KTG, kadar asam laktat tali pusat janin baru lahir dan Skor APGAR bayi baru lahir pada ibu hamil normal dan hamil risiko tinggi trimester III.
Metode: Penelitian ini merupakan penelitian analitik observasional dengan desain penelitian kasus kontrol. Sampel yaitu ibu hamil trimester III yang akan diterminasi sesuai dengan kriteria inklusi. Sampel sebanyak 25 kelompok hamil normal dan 25 hamil risiko tinggi. Data dianalisis menggunakan statistik.
Hasil: Subjek penelitian terbanyak usia 20-35 tahun pada kedua kelompok, usia kehamilan terbanyak yaitu aterm pada kedua kelompok, paritas terbanyak primigravida pada hamil risiko tinggi, dan multigravida pada hamil normal, cara persalinan terbanyak perabdominal pada hamil risiko tinggi, dan pervaginam pada hamil normal. Tidak ada perbedaan S/D Rasio, Pulsatil Index, Resistensi Index, Asam Laktat dan Skor APGAR pada kelompok ibu hamil risiko tinggi dan hamil normal. Tidak ada perbedaan KTG pada kedua kelompok. Tidak terdapat korelasi S/D Rasio, Pulsatil Index dan Resistensi Index dengan Asam Laktat pada kelompok ibu hamil risiko tinggi dengan hamil normal. Tidak terdapat korelasi S/D Rasio, Pulsatil Index dan Resistensi Index dengan Skor Apgar pada kelompok ibu hamil risiko tinggi dengan hamil normal.
Kesimpulan: Tidak ada perbedaan doppler umbilikal arteri, KTG, kadar asam laktat tali pusat janin baru lahir dan skor APGAR pada ibu hamil normal dan hamil risiko tinggi trimester III.Background: The high mortality rate of newborns due to asphyxia shows a lack of treatment and comprehensive prevention in newborns. There for an effective and efficient examination is needed in predicting the risk of fetal distress.
Objective: To evaluate the differences in fetal umbilical artery doppler examination, CTG, lactic acid levels of the newborn's umbilical cord and APGAR score of newborns in third trimester normal and high-risk pregnancy.
Method: This research is an observational analytic study with a case control design. The sample are third trimester women whom plan to be terminated according to inclusion criteria. According to the total sample count of 25 normal and 25 high-risk pregnancy groups. Data were analyzed using statistics.
Results: The most subjects are 20-35 years old in both groups, the highest gestational age are term in both groups, primigravida in high-risk pregnancies, and multigravida in normal pregnancies, the most common methods for giving birth in high-risk pregnancies are caesarean section, and vaginal birth in normal pregnancies. There were no differences in S/D Ratio, Pulsatile Index, Resistance Index, Lactic Acid and APGAR Score in high risk and normal pregnancy groups. There were no differences in CTG between both groups. There is no correlation of S/D Ratio, Pulsatil Index and Resistance Index with Lactic Acid in high risk and normal groups. There is no correlation of S/D Ratio, Pulsatil Index and Resistance Index with Apgar Score in high risk and normal groups.
Conclusion: There are no differences in umbilical artery doppler examination, CTG, lactic acid levels of the newborn umbilical cord and APGAR score in normal and high-risk pregnancy third trimester.101 HalamanTesis Magiste
Prevalensi Trombosis Vena dalam (Deep Vein Thrombosis) dengan Compression Ultrasound B-Mode Image pada Pasien Tumor Ginekologi Resiko Tinggi dan Resiko Rendah di RS H. Adam Malik Medan
No full textTujuan : Untuk mengetahui prevalensi trombosis vena dalam pada pasien-pasien tumor ginekologi dengan menggunakan pemeriksaan compression ultrasound b-mode image berdasarkan stratifikasi faktor risiko tinggi dan risiko rendah, untuk mengetahui odds ratio kejadian trombosis vena dalam dan apakah ada perbedaan proporsi trombosis vena dalam pada pasien tumor ganas ginekologi dengan tumor jinak ginekologi.
Tempat : RSUP. H Adam Malik Medan.
Rancangan Penelitian : Penelitian observasional analitik dengan disain potong lintang
Metode Penelitian : Semua pasien dengan tumor ginekologi dibagi atas resiko rendah dan resiko tinggi berdasarkan modifikasi skoring Venous Thromboembolism Risk Factor Assessment dari Joseph A. Caprini. Kemudian dilakukan compression ultrasound b-mode image pada kedua ekstremitas bawah. Dilakukan penyajian dan analisis data, lalu dihitung risiko relatif kejadian DVT pada resiko tinggi dan pada tumor ganas ginekologi.
Hasil penelitian : Didapatkan 206 subjek penelitian dengan proporsi DVT pada resiko tinggi 26.5%, resiko rendah 3.4%, prevalensi DVT pada resiko tinggi 149 per 1000 populasi beresiko, resiko rendah 14 per 1000 populasi beresiko. Proporsi DVT pada tumor jinak ginekologi 3.7%, tumor ganas ginekologi 24.7%, prevalensi DVT pada tumor jinak ginekologi 14 per 1000 populasi beresiko, tumor ganas ginekologi 116 per 1000 populasi beresiko. Didapatkan perbedaan bermakna kejadian DVT pada resiko tinggi dan resiko rendah (p=0.000) dan perbedaan bermakna kejadian DVT pada tumor ganas dan tumor jinak ginekologi (p=0.000). Odds ratio menderita DVT pada risiko tinggi sebesar 10.3 kali lipat dibandingkan risiko rendah. Dan odds ratio menderita DVT pada tumor ganas sebesar 8.7 kali lipat dibandingkan dengan tumor jinak. Dijumpai hubungan yang bermakna antara gejala klinis dengan kejadian DVT (p=0.000).
Kesimpulan : Prevalensi DVT pada pasien tumor ginekologi risiko tinggi adalah 149 per 1000 populasi beresiko sedangkan pada pasien tumor ginekologi risiko rendah adalah 14 per 1000 populasi beresiko.
Kata Kunci : DVT (deep vein thrombosis), tumor ginekologi, Venous Thromboembolism Risk Factor Assessment, risiko tinggi, risiko rendah, compression ultrasound b-mode image.53 HalamanTesis Magiste
Tingkat Kepuasan Seksual pada Paeisn Plasenta Akreta Pasca Histerektomi
Get PDFBackground: Placenta accreta is often used as a general term but is defined by the levels of invasion of chorionic villi into maternal myometrium. Once a rare diagnosis, it is now the leading cause of postpartum hemorrhage and indication for a gravid hysterectomy. Although many advantages of hysterectomy have been known, it is still unknown how it affects the vaginal length and sexual functioning. Studies that discuss specifically about the relationship of sexual satisfaction index of placenta accrete patients after hysterectomy or conservative have not been found.Objective: To determine the sexual satisfaction index of patients with placenta accreta after hysterectomy.Method: This study is an observational study with analytical approach, with cross sectional design. The sample is placenta accreta patients in RSUP HAM Medan which fulfill the inlusion and exclusion criteria and taken by total sampling. The data is primary and secondary which taken from RSUP HAM Medan medical report and through interviews by mobile device due the COVID-19 Pandemic, using FSFI (Female Sexual Function Index) questionnaire that has been validated into Indonesian.Results and Discussion: From 92 placenta accreta patients, the most placenta accreta age is 5 (62.5%). Placenta accreta sexual satisfaction with hysterectomy as treatment has FSFI total score ≥ 26.55 (15.0%) and < 26.55 (85%). Placenta accreta sexual satisfaction without hysterectomy as therapy (conservative) has FSFI total score FSFI ≥ 26.55 (0%) and 26.55 (100%). On Fisher Exact Test the p value = 1,000 (p <0.05).Conclusion: There is no difference between placenta accreta sexual satisfaction with or without hysterectomy (conservative)
- …
